Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - NantHealth, Inc. | exhibit32212312019.htm |
| EX-32.1 - EXHIBIT 32.1 - NantHealth, Inc. | exhibit32112312019.htm |
| EX-31.2 - EXHIBIT 31.2 - NantHealth, Inc. | exhibit31212312019.htm |
| EX-31.1 - EXHIBIT 31.1 - NantHealth, Inc. | exhibit31112312019.htm |
| EX-24.1 - EXHIBIT 24.1 - NantHealth, Inc. | exhibit24112312019.htm |
| EX-21.1 - EXHIBIT 21.1 - NantHealth, Inc. | exhibit21112312019.htm |
| EX-4.1 - EXHIBIT 4.1 - NantHealth, Inc. | exhibit41descriptionofsecu.htm |
| EX-2.1 - EXHIBIT 2.1 - NantHealth, Inc. | exhibit21apa-victorio.htm |
| 10-K - 10-K - NantHealth, Inc. | a1231201910k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-3 No. 333-223744) of NantHealth, Inc., and |
(2) | Registration Statement (Form S-8 Nos. 333-211886 and 333-225670) pertaining to the 2016 Equity Incentive Plan and Phantom Unit Plan of NantHealth, Inc. |
of our report dated February 28, 2020, with respect to the consolidated financial statements of NantHealth, Inc., included in this Annual Report (Form 10-K) of NantHealth, Inc. for the year ended December 31, 2019.
/s/ Ernst & Young LLP | |
Los Angeles, California | |
February 28, 2020 | |